News

Built on MVE’s legacy SC 4/2V and 4/3V vapor shipper platform, the next-generation SC 4/2V and 4/3V models have been ...
Celltrion USA announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia ...
Centauri Therapeutics Limited, an immunotherapy company, has appointed Dr. Debra Barker as Chief Medical Officer (CMO).
Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) of Hansa Biopharma AB, effective July 14.